| |
|
|
|
Biocryst Pharma Inc
|
|
4.10 0 (+0.00%) |
8/18/2017 4:00pm |
|
Open: |
4.06 |
Pre close: |
4.10 |
Target:
|
6.01 
|
|
High: |
4.14 |
Low: |
4.00 |
Resistance:
|
5.15
5.86
|
|
Volume: |
632,163 |
Market Cap: |
329.75M |
Support:
|
4.00
3.33
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.28
|
MACD |
MACD(12,26):
|
-0.34 |
|
MA(20): |
4.73 |
Signal(12,26,9): |
-0.30 |
|
MA(100): |
5.83 |
Stochastic Oscillator |
%K(14,3):
|
3.12 |
|
MA(250): |
5.76 |
%D(3): |
6.95 |
|
Average Volume(K) |
3-Month: |
146559
|
52-Week |
High:
|
9.25 |
|
10-Days: |
43910 |
Low: |
3.75 |
|
RSI |
RSI(14):
|
29.38 |
Change(%): |
-7.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.630 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
80.42 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
56.41 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
-0.31 |
% Held by Insiders |
1.38 |
|
EPS Est. Next Quarter |
-0.170 |
Qtrly Rev. Growth |
-35.3 |
% Held by Institutions |
87.50 |
|
Forward EPS |
-0.750 |
Gross Profit (p.s.) |
0.299 |
Shares Short (K) |
11590 |
|
Book Value (p.s.) |
0.480 |
EBITDA (p.s.) |
-0.534 |
P/E |
-6.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.54 |
|
Profit Margin |
-160.97 |
Operating Cash Flow
(M) |
0.00 |
P/S |
845441024.00 |
|
Operating Margin |
-149.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
 |
|
|
|
